Articles

Elsevier,

eClinicalMedicine, Volume 54, December 2022

This Article supports SDG 3 by examining the potential impact of WHO's triple-intervention elimination strategy on cervical cancer incidence among women with HIV in South Africa. The authors note that cervical cancer elimination among women with HIV would necessitate more frequent screening (every 3 years).
Elsevier,

The Lancet HIV, Volume 9, December 2022

This Article supports SDG 3 by examining the potential impact of WHO's triple-intervention elimination strategy on cervical cancer incidence among women with HIV in South Africa. The authors note that cervical cancer elimination among women with HIV would necessitate more frequent screening (every 3 years).
Elsevier,

Cancer Treatment Reviews,
Volume 112,
2023,
102491,
ISSN 0305-7372

Experts in the field, along with patient representatives from the Sarcoma Patient Advocacy Global Network (SPAGN), met at an international consensus meeting in 2022 to define best clinical practice of tenosynovial giant cell tumour (TGCT). Although usually not life-threatening, TGCT may cause chronic pain and adversely impact function and quality of life. A global effort is needed to make active systemic treatments available to TGCT patients worldwide and avoid discrimination.
Elsevier,

The Lancet, Volume 400, Issue 10368, 10–16 December 2022, Pages 2049-2062

This Article supports SDGs 3 and 10 by showing that, globally, Black women are at higher risk of adverse perinatal outcomes of neonatal death, stillbirth, preterm birth, and small-for-gestational-age babies than White women, even after adjusting for maternal characteristics. Moreover, these racial disparities in perinatal outcomes were consistently observed across all geographical regions.
Elsevier,

Antiviral Research, Volume 208, December 2022

Cabotegravir (CAB) is an integrase strand transfer inhibitor (INSTI) formulated as a long-acting injectable drug approved for pre-exposure prophylaxis and use with a long acting rilpivirine formulation for therapy in patients with virological suppression. However, there has been no comprehensive review of the genetic mechanisms of CAB resistance. Studies reporting the selection of drug resistance mutations (DRMs) by CAB and the results of in vitro CAB susceptibility testing were reviewed.
Elsevier,

Vaccine: X, Volume 12, December 2022

An ongoing challenge in HIV-1 vaccine research is finding a novel HIV-1 envelope glycoprotein (Env)-based immunogen that elicits broadly cross-neutralizing antibodies (bnAbs) without requiring complex sequential immunization regimens to drive the required antibody affinity maturation. 
Elsevier,

Transportation Research Part D: Transport and Environment, Volume 113, December 2022

In support of SDG 5 and 11, this Study discusses which transport infrastructure innovations are required to support gender-equitable cycling, especially in developing countries.
Figure 1. Maternal physiological responses to thermal heat stress
Elsevier,

The Lancet Planetary Health, Volume 6, Issue 12, December 2022, Pages e968-e976

This Article supports SDGs 3, 5, and 13, focusing on the mechanisms for adverse outcomes caused by environmental heat stress in pregnant subsistence farmers.
Elsevier,

The Lancet Planetary Health, Volume 6, Issue 12, December 2022, Pages e941-e948

This Article supports SDGs 3 and 13 by estimating cost and benefits of climate change mitigation, focussing on heat-related labour losses and considering current mitigation pledges.
Elsevier,

The Lancet Regional Health - Southeast Asia, Volume 7, December 2022

This Article supports SDG 8,9 and 10, by examining the direct relation between economic inequity and burden of disease due to air pollution in India considering time trends from 2011-2019.

Pages